During the past decade, Università Cattolica del Sacro Cuore conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università Cattolica del Sacro Cuore" #1 sponsor was "National Cancer Institute, Naples" with 6 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Cyclacel Pharmaceuticals, Inc." with 1 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 1 trials sponsored and "Mauro Biffi" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Cattolica del Sacro Cuore" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Research Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Università Cattolica del Sacro Cuore" are "Ovarian Cancer" (6 trials), "Acute Myeloid Leukemia" (1 trials), "B-cell Lymphoma" (1 trials), "Cervical Cancer" (1 trials) and "Device Replacement" (1 trials). Many other conditions were trialed in "Università Cattolica del Sacro Cuore" in a lesser frequency.

Most popular intervention types in "Università Cattolica del Sacro Cuore" are "Drug" (9 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (5 trials), "paclitaxel" (5 trials), "Rituximab" (3 trials), "Prednisone" (2 trials) and "ARA-C" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università Cattolica del Sacro Cuore" are 7 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Università Cattolica del Sacro Cuore". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Università Cattolica del Sacro Cuore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Università Cattolica del Sacro Cuore, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".